

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.84495573 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 5.49502017 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.49502017 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.49502017 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.49502017 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.49502017 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.49502017 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 5.39577918 |
| 9 | glycosphingolipid catabolic process (GO:0046479) | 4.81351636 |
| 10 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.79231720 |
| 11 | positive regulation of interferon-alpha production (GO:0032727) | 4.79145015 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 4.54713453 |
| 13 | respiratory burst (GO:0045730) | 4.53816054 |
| 14 | regulation of interferon-alpha production (GO:0032647) | 4.51479433 |
| 15 | response to peptidoglycan (GO:0032494) | 4.48536741 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 4.40152637 |
| 17 | glycolipid catabolic process (GO:0019377) | 4.32765879 |
| 18 | oligosaccharide catabolic process (GO:0009313) | 4.30916091 |
| 19 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.26903770 |
| 20 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.21140127 |
| 21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.08173248 |
| 22 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.99074652 |
| 23 | amino sugar catabolic process (GO:0046348) | 3.93234550 |
| 24 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.91587237 |
| 25 | positive regulation of antigen processing and presentation (GO:0002579) | 3.86535115 |
| 26 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.84673584 |
| 27 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.84673584 |
| 28 | reactive oxygen species biosynthetic process (GO:1903409) | 3.80408642 |
| 29 | ceramide catabolic process (GO:0046514) | 3.78428354 |
| 30 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.67777427 |
| 31 | granulocyte activation (GO:0036230) | 3.67303787 |
| 32 | microglial cell activation (GO:0001774) | 3.62422945 |
| 33 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.55597969 |
| 34 | response to host immune response (GO:0052572) | 3.55597969 |
| 35 | neutrophil activation (GO:0042119) | 3.54560776 |
| 36 | positive regulation of interferon-beta production (GO:0032728) | 3.49808261 |
| 37 | macrophage activation (GO:0042116) | 3.48666694 |
| 38 | NIK/NF-kappaB signaling (GO:0038061) | 3.47973209 |
| 39 | response to thyroid hormone (GO:0097066) | 3.40113516 |
| 40 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.38958314 |
| 41 | myeloid cell activation involved in immune response (GO:0002275) | 3.38556743 |
| 42 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.34471596 |
| 43 | B cell mediated immunity (GO:0019724) | 3.33744108 |
| 44 | detection of molecule of bacterial origin (GO:0032490) | 3.32921764 |
| 45 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.32762648 |
| 46 | regulation of antigen processing and presentation (GO:0002577) | 3.32168301 |
| 47 | adhesion of symbiont to host cell (GO:0044650) | 3.31724773 |
| 48 | virion attachment to host cell (GO:0019062) | 3.31724773 |
| 49 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.30523091 |
| 50 | barbed-end actin filament capping (GO:0051016) | 3.28738687 |
| 51 | natural killer cell mediated immunity (GO:0002228) | 3.27593950 |
| 52 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.27593950 |
| 53 | superoxide anion generation (GO:0042554) | 3.26078817 |
| 54 | response to muramyl dipeptide (GO:0032495) | 3.25127100 |
| 55 | N-acetylneuraminate metabolic process (GO:0006054) | 3.24285486 |
| 56 | membrane lipid catabolic process (GO:0046466) | 3.22504066 |
| 57 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.21773366 |
| 58 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.20061460 |
| 59 | regulation of mononuclear cell migration (GO:0071675) | 3.18713005 |
| 60 | regulation of cholesterol storage (GO:0010885) | 3.17370041 |
| 61 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.16751859 |
| 62 | leukocyte mediated cytotoxicity (GO:0001909) | 3.16518746 |
| 63 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.15808325 |
| 64 | negative regulation of cell killing (GO:0031342) | 3.15808325 |
| 65 | type I interferon signaling pathway (GO:0060337) | 3.14660079 |
| 66 | cellular response to type I interferon (GO:0071357) | 3.14660079 |
| 67 | sphingolipid catabolic process (GO:0030149) | 3.14415862 |
| 68 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.14019897 |
| 69 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.13560686 |
| 70 | response to host (GO:0075136) | 3.13560686 |
| 71 | response to host defenses (GO:0052200) | 3.13560686 |
| 72 | regulation of podosome assembly (GO:0071801) | 3.13460325 |
| 73 | detection of other organism (GO:0098543) | 3.12922421 |
| 74 | response to type I interferon (GO:0034340) | 3.11564379 |
| 75 | regulation of macrophage chemotaxis (GO:0010758) | 3.10935007 |
| 76 | protein localization to endosome (GO:0036010) | 3.08635116 |
| 77 | positive regulation of leukocyte degranulation (GO:0043302) | 3.08070114 |
| 78 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.07465897 |
| 79 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.06561871 |
| 80 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.03252130 |
| 81 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.02374227 |
| 82 | germinal center formation (GO:0002467) | 3.02253531 |
| 83 | low-density lipoprotein particle clearance (GO:0034383) | 3.00978596 |
| 84 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.99864282 |
| 85 | adhesion of symbiont to host (GO:0044406) | 2.99856630 |
| 86 | positive regulation of mast cell activation (GO:0033005) | 2.98822896 |
| 87 | regulation of leukocyte degranulation (GO:0043300) | 2.98504202 |
| 88 | detection of external biotic stimulus (GO:0098581) | 2.96874937 |
| 89 | cellular response to zinc ion (GO:0071294) | 2.96681918 |
| 90 | cellular response to interferon-beta (GO:0035458) | 2.96015749 |
| 91 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.95925832 |
| 92 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.95505170 |
| 93 | myeloid dendritic cell differentiation (GO:0043011) | 2.94725214 |
| 94 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.93837558 |
| 95 | monocyte chemotaxis (GO:0002548) | 2.92592974 |
| 96 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.92508400 |
| 97 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.92380830 |
| 98 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.92354716 |
| 99 | regulation of mast cell degranulation (GO:0043304) | 2.92162603 |
| 100 | T-helper 1 type immune response (GO:0042088) | 2.91572220 |
| 101 | detection of bacterium (GO:0016045) | 2.89567062 |
| 102 | positive regulation of B cell differentiation (GO:0045579) | 2.89432914 |
| 103 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.87177080 |
| 104 | regulation of chemokine biosynthetic process (GO:0045073) | 2.86243680 |
| 105 | response to interferon-alpha (GO:0035455) | 2.85760699 |
| 106 | pinocytosis (GO:0006907) | 2.85303847 |
| 107 | regulation of vitamin metabolic process (GO:0030656) | 2.85226192 |
| 108 | cellular extravasation (GO:0045123) | 2.85012440 |
| 109 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.84088246 |
| 110 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.83392348 |
| 111 | response to interferon-beta (GO:0035456) | 2.82863025 |
| 112 | mannose metabolic process (GO:0006013) | 2.82686770 |
| 113 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.82400305 |
| 114 | defense response to protozoan (GO:0042832) | 2.82089050 |
| 115 | negative regulation of interleukin-17 production (GO:0032700) | 2.81810908 |
| 116 | neutrophil mediated immunity (GO:0002446) | 2.81751077 |
| 117 | myeloid dendritic cell activation (GO:0001773) | 2.79628430 |
| 118 | regulation of mast cell activation (GO:0033003) | 2.78830888 |
| 119 | positive regulation of mast cell degranulation (GO:0043306) | 2.78472953 |
| 120 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.78472953 |
| 121 | myeloid leukocyte activation (GO:0002274) | 2.76683357 |
| 122 | response to protozoan (GO:0001562) | 2.75900543 |
| 123 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.75497528 |
| 124 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.74909838 |
| 125 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.74670007 |
| 126 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.74546261 |
| 127 | positive regulation of interleukin-12 production (GO:0032735) | 2.74429801 |
| 128 | regulation of superoxide anion generation (GO:0032928) | 2.74087618 |
| 129 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.73441907 |
| 130 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.72373963 |
| 131 | regulation of monocyte chemotaxis (GO:0090025) | 2.71597091 |
| 132 | I-kappaB phosphorylation (GO:0007252) | 2.71173851 |
| 133 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.70966901 |
| 134 | dendritic cell differentiation (GO:0097028) | 2.70863559 |
| 135 | negative regulation of mast cell activation (GO:0033004) | 2.70099656 |
| 136 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.69695576 |
| 137 | negative regulation of lipid storage (GO:0010888) | 2.67534423 |
| 138 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.66720732 |
| 139 | negative regulation of interleukin-12 production (GO:0032695) | 2.65487133 |
| 140 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.65391973 |
| 141 | regulation of interferon-beta production (GO:0032648) | 2.64769537 |
| 142 | apoptotic cell clearance (GO:0043277) | 2.63425981 |
| 143 | positive regulation of chemokine production (GO:0032722) | 2.63289027 |
| 144 | peptide catabolic process (GO:0043171) | 2.63052418 |
| 145 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.62863570 |
| 146 | regulation of growth of symbiont in host (GO:0044126) | 2.62863570 |
| 147 | negative regulation of growth of symbiont in host (GO:0044130) | 2.62863570 |
| 148 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.62863570 |
| 149 | cellular response to interferon-gamma (GO:0071346) | 2.61969107 |
| 150 | cellular response to lipopolysaccharide (GO:0071222) | 2.60645225 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.46082960 |
| 2 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.13008988 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.03665164 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.10859260 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.74040020 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.71901432 |
| 7 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.45364095 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.42941085 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.19960440 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.03678396 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.87068748 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.77614336 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.70490546 |
| 14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.69919117 |
| 15 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.61972676 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.56954698 |
| 17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.24774800 |
| 18 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.22006100 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.19812246 |
| 20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.14962397 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.06000725 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.04020547 |
| 23 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.98860576 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.98021241 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.95724608 |
| 26 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.91271475 |
| 27 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.86122491 |
| 28 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.80714579 |
| 29 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.78429500 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76794318 |
| 31 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.76604130 |
| 32 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.74267407 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.70048416 |
| 34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.69788714 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.68910391 |
| 36 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.66603900 |
| 37 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.65600640 |
| 38 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.65554690 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.61262070 |
| 40 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.59395705 |
| 41 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.57393103 |
| 42 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.56640704 |
| 43 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.54528591 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51293395 |
| 45 | MYB_26560356_Chip-Seq_TH2_Human | 1.50511498 |
| 46 | SPI1_23127762_ChIP-Seq_K562_Human | 1.48122082 |
| 47 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.47016645 |
| 48 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45548398 |
| 49 | MAF_26560356_Chip-Seq_TH1_Human | 1.44159338 |
| 50 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.41845927 |
| 51 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.41761199 |
| 52 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.40370390 |
| 53 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.35227076 |
| 54 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34234243 |
| 55 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.34206722 |
| 56 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.31385919 |
| 57 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.30543041 |
| 58 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.28684292 |
| 59 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28490300 |
| 60 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26524368 |
| 61 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.25775243 |
| 62 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25052113 |
| 63 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24757054 |
| 64 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.23446266 |
| 65 | * MYB_26560356_Chip-Seq_TH1_Human | 1.23375971 |
| 66 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.22932830 |
| 67 | GATA1_19941826_ChIP-Seq_K562_Human | 1.22084430 |
| 68 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.21982127 |
| 69 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21155139 |
| 70 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.20561849 |
| 71 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.17362477 |
| 72 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17275164 |
| 73 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.17098864 |
| 74 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16103504 |
| 75 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.15098021 |
| 76 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14678056 |
| 77 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.10332234 |
| 78 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09480165 |
| 79 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.08639397 |
| 80 | KDM2B_26808549_Chip-Seq_K562_Human | 1.07232332 |
| 81 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04250803 |
| 82 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04181532 |
| 83 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04157838 |
| 84 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04004281 |
| 85 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.02443182 |
| 86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02028611 |
| 87 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01142765 |
| 88 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.00623104 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.98299837 |
| 90 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98168487 |
| 91 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97664849 |
| 92 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.97574093 |
| 93 | UTX_26944678_Chip-Seq_JUKART_Human | 0.96480338 |
| 94 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.96314105 |
| 95 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95548679 |
| 96 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94971029 |
| 97 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94539838 |
| 98 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.91868092 |
| 99 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90866808 |
| 100 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.85173039 |
| 101 | MAF_26560356_Chip-Seq_TH2_Human | 0.83517239 |
| 102 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.83242815 |
| 103 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82765175 |
| 104 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.82704540 |
| 105 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.81093465 |
| 106 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.80822560 |
| 107 | MYC_22102868_ChIP-Seq_BL_Human | 0.79331786 |
| 108 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.78133082 |
| 109 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.77473143 |
| 110 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.76613166 |
| 111 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.75679067 |
| 112 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.75154554 |
| 113 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.74422931 |
| 114 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.74383645 |
| 115 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.73907057 |
| 116 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.73155789 |
| 117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.73037979 |
| 118 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.71076181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.47017551 |
| 2 | MP0003436_decreased_susceptibility_to | 3.63776697 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.57049977 |
| 4 | MP0009785_altered_susceptibility_to | 3.15241186 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.11099060 |
| 6 | MP0006082_CNS_inflammation | 3.09436292 |
| 7 | MP0002419_abnormal_innate_immunity | 3.04899845 |
| 8 | MP0003303_peritoneal_inflammation | 2.93003434 |
| 9 | MP0009840_abnormal_foam_cell | 2.89834098 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.78523131 |
| 11 | MP0005025_abnormal_response_to | 2.68414611 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.55269872 |
| 13 | MP0005387_immune_system_phenotype | 2.46892979 |
| 14 | MP0001790_abnormal_immune_system | 2.46892979 |
| 15 | MP0000685_abnormal_immune_system | 2.45563953 |
| 16 | MP0003724_increased_susceptibility_to | 2.43126448 |
| 17 | MP0003172_abnormal_lysosome_physiology | 2.41019151 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.40874792 |
| 19 | MP0005671_abnormal_response_to | 2.25145653 |
| 20 | MP0001800_abnormal_humoral_immune | 2.18980038 |
| 21 | MP0002723_abnormal_immune_serum | 2.17932405 |
| 22 | MP0005451_abnormal_body_composition | 2.12767218 |
| 23 | MP0004510_myositis | 2.11234933 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.09949855 |
| 25 | MP0001533_abnormal_skeleton_physiology | 2.05445420 |
| 26 | MP0001819_abnormal_immune_cell | 1.96422835 |
| 27 | MP0002420_abnormal_adaptive_immunity | 1.93497063 |
| 28 | MP0001853_heart_inflammation | 1.83728068 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.80948334 |
| 30 | MP0008469_abnormal_protein_level | 1.78179405 |
| 31 | MP0009764_decreased_sensitivity_to | 1.73829139 |
| 32 | MP0002405_respiratory_system_inflammati | 1.71217554 |
| 33 | MP0004947_skin_inflammation | 1.65475549 |
| 34 | MP0000343_altered_response_to | 1.64203652 |
| 35 | MP0003806_abnormal_nucleotide_metabolis | 1.62368016 |
| 36 | MP0003075_altered_response_to | 1.57183086 |
| 37 | MP0008438_abnormal_cutaneous_collagen | 1.55487384 |
| 38 | MP0000604_amyloidosis | 1.54045898 |
| 39 | MP0003186_abnormal_redox_activity | 1.46031264 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.45475116 |
| 41 | * MP0003448_altered_tumor_morphology | 1.42865046 |
| 42 | MP0000716_abnormal_immune_system | 1.40960637 |
| 43 | MP0002998_abnormal_bone_remodeling | 1.40899074 |
| 44 | MP0003329_amyloid_beta_deposits | 1.39692192 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.37460043 |
| 46 | MP0005310_abnormal_salivary_gland | 1.36333215 |
| 47 | MP0002139_abnormal_hepatobiliary_system | 1.32350884 |
| 48 | MP0002006_tumorigenesis | 1.28649632 |
| 49 | MP0003195_calcinosis | 1.28621312 |
| 50 | MP0006054_spinal_hemorrhage | 1.28469713 |
| 51 | MP0004782_abnormal_surfactant_physiolog | 1.26271750 |
| 52 | MP0008004_abnormal_stomach_pH | 1.26241522 |
| 53 | MP0005166_decreased_susceptibility_to | 1.26100895 |
| 54 | MP0003690_abnormal_glial_cell | 1.25903869 |
| 55 | MP0002877_abnormal_melanocyte_morpholog | 1.25616234 |
| 56 | MP0005360_urolithiasis | 1.24544694 |
| 57 | MP0002398_abnormal_bone_marrow | 1.23598246 |
| 58 | MP0002166_altered_tumor_susceptibility | 1.23084750 |
| 59 | MP0000689_abnormal_spleen_morphology | 1.21605201 |
| 60 | MP0003300_gastrointestinal_ulcer | 1.18720974 |
| 61 | MP0003183_abnormal_peptide_metabolism | 1.17866739 |
| 62 | MP0002429_abnormal_blood_cell | 1.16291705 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 1.16061188 |
| 64 | MP0002138_abnormal_hepatobiliary_system | 1.15317147 |
| 65 | MP0005257_abnormal_intraocular_pressure | 1.13402665 |
| 66 | MP0003091_abnormal_cell_migration | 1.11054239 |
| 67 | MP0005164_abnormal_response_to | 1.09147851 |
| 68 | MP0003279_aneurysm | 1.09115106 |
| 69 | * MP0000858_altered_metastatic_potential | 1.09067168 |
| 70 | MP0001545_abnormal_hematopoietic_system | 1.06588080 |
| 71 | MP0005397_hematopoietic_system_phenotyp | 1.06588080 |
| 72 | MP0009763_increased_sensitivity_to | 1.06507247 |
| 73 | MP0000920_abnormal_myelination | 1.05950846 |
| 74 | MP0002722_abnormal_immune_system | 1.05142094 |
| 75 | MP0002254_reproductive_system_inflammat | 1.04643278 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 1.03028448 |
| 77 | MP0009278_abnormal_bone_marrow | 1.02613219 |
| 78 | MP0005083_abnormal_biliary_tract | 0.99115495 |
| 79 | MP0005390_skeleton_phenotype | 0.98991727 |
| 80 | MP0003566_abnormal_cell_adhesion | 0.97401655 |
| 81 | MP0000609_abnormal_liver_physiology | 0.96010889 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 0.95268878 |
| 83 | MP0002933_joint_inflammation | 0.94946529 |
| 84 | MP0005165_increased_susceptibility_to | 0.92438421 |
| 85 | MP0010329_abnormal_lipoprotein_level | 0.91229611 |
| 86 | MP0005319_abnormal_enzyme/_coenzyme | 0.89622116 |
| 87 | MP0001542_abnormal_bone_strength | 0.87786744 |
| 88 | MP0000249_abnormal_blood_vessel | 0.85978624 |
| 89 | MP0000371_diluted_coat_color | 0.83663465 |
| 90 | MP0001849_ear_inflammation | 0.83178092 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.82163794 |
| 92 | MP0000465_gastrointestinal_hemorrhage | 0.81547830 |
| 93 | MP0001958_emphysema | 0.80847322 |
| 94 | MP0001663_abnormal_digestive_system | 0.76355234 |
| 95 | MP0005365_abnormal_bile_salt | 0.75925753 |
| 96 | MP0001851_eye_inflammation | 0.75542264 |
| 97 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75188413 |
| 98 | MP0000598_abnormal_liver_morphology | 0.74564825 |
| 99 | MP0004883_abnormal_blood_vessel | 0.73864500 |
| 100 | MP0005076_abnormal_cell_differentiation | 0.73582040 |
| 101 | MP0003795_abnormal_bone_structure | 0.73323739 |
| 102 | MP0003634_abnormal_glial_cell | 0.73061208 |
| 103 | MP0009643_abnormal_urine_homeostasis | 0.72883203 |
| 104 | MP0000569_abnormal_digit_pigmentation | 0.69893526 |
| 105 | MP0003252_abnormal_bile_duct | 0.69479503 |
| 106 | MP0008874_decreased_physiological_sensi | 0.69434101 |
| 107 | MP0005023_abnormal_wound_healing | 0.68192399 |
| 108 | MP0005085_abnormal_gallbladder_physiolo | 0.68102443 |
| 109 | MP0002332_abnormal_exercise_endurance | 0.67344931 |
| 110 | MP0003828_pulmonary_edema | 0.66486476 |
| 111 | MP0003453_abnormal_keratinocyte_physiol | 0.66165044 |
| 112 | MP0002277_abnormal_respiratory_mucosa | 0.65905791 |
| 113 | MP0008260_abnormal_autophagy | 0.65181991 |
| 114 | MP0008875_abnormal_xenobiotic_pharmacok | 0.65057872 |
| 115 | MP0004019_abnormal_vitamin_homeostasis | 0.64191292 |
| 116 | MP0002090_abnormal_vision | 0.63954093 |
| 117 | MP0000490_abnormal_crypts_of | 0.62657175 |
| 118 | MP0005595_abnormal_vascular_smooth | 0.61796269 |
| 119 | MP0005647_abnormal_sex_gland | 0.58958802 |
| 120 | MP0009765_abnormal_xenobiotic_induced | 0.58266438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.51217416 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.16844976 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.04179432 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.93344998 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 5.18031478 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 5.16210541 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.82715753 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 4.49446244 |
| 9 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.03099624 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 3.93051671 |
| 11 | Autoimmune thrombocytopenia (HP:0001973) | 3.88777697 |
| 12 | Dysostosis multiplex (HP:0000943) | 3.84858255 |
| 13 | Abnormality of glycolipid metabolism (HP:0010969) | 3.84082515 |
| 14 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.84082515 |
| 15 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.84082515 |
| 16 | Recurrent skin infections (HP:0001581) | 3.76880910 |
| 17 | Glomerulonephritis (HP:0000099) | 3.73746655 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.71245110 |
| 19 | Axonal loss (HP:0003447) | 3.63390162 |
| 20 | Gingivitis (HP:0000230) | 3.58867021 |
| 21 | Neurofibrillary tangles (HP:0002185) | 3.58269413 |
| 22 | Mutism (HP:0002300) | 3.51047933 |
| 23 | Myositis (HP:0100614) | 3.39889839 |
| 24 | Mucopolysacchariduria (HP:0008155) | 3.21384131 |
| 25 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.21384131 |
| 26 | Nuclear cataract (HP:0100018) | 3.20167629 |
| 27 | Obstructive lung disease (HP:0006536) | 3.19324422 |
| 28 | Chronic obstructive pulmonary disease (HP:0006510) | 3.19324422 |
| 29 | Orchitis (HP:0100796) | 3.11027049 |
| 30 | Recurrent fungal infections (HP:0002841) | 3.10512639 |
| 31 | Myocardial infarction (HP:0001658) | 3.10242989 |
| 32 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.03224579 |
| 33 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.97340177 |
| 34 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.97340177 |
| 35 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.97340177 |
| 36 | Complement deficiency (HP:0004431) | 2.93604801 |
| 37 | Basal ganglia calcification (HP:0002135) | 2.89404307 |
| 38 | Disinhibition (HP:0000734) | 2.87678064 |
| 39 | Interstitial pulmonary disease (HP:0006530) | 2.87447434 |
| 40 | Abnormality of complement system (HP:0005339) | 2.85511931 |
| 41 | Joint hemorrhage (HP:0005261) | 2.82727181 |
| 42 | Periodontitis (HP:0000704) | 2.82216119 |
| 43 | Pustule (HP:0200039) | 2.82118847 |
| 44 | Apathy (HP:0000741) | 2.78198747 |
| 45 | Diminished motivation (HP:0000745) | 2.73285474 |
| 46 | Vasculitis (HP:0002633) | 2.71898178 |
| 47 | Recurrent viral infections (HP:0004429) | 2.70663161 |
| 48 | Cerebral inclusion bodies (HP:0100314) | 2.69918109 |
| 49 | Retrobulbar optic neuritis (HP:0100654) | 2.69168258 |
| 50 | Optic neuritis (HP:0100653) | 2.69168258 |
| 51 | Cellulitis (HP:0100658) | 2.67179011 |
| 52 | Neuronal loss in central nervous system (HP:0002529) | 2.62138102 |
| 53 | Urticaria (HP:0001025) | 2.59824169 |
| 54 | Nephritis (HP:0000123) | 2.55628111 |
| 55 | Tetraparesis (HP:0002273) | 2.53569719 |
| 56 | Hepatosplenomegaly (HP:0001433) | 2.52408872 |
| 57 | Chronic otitis media (HP:0000389) | 2.52061204 |
| 58 | Loss of speech (HP:0002371) | 2.51422924 |
| 59 | Stomatitis (HP:0010280) | 2.48355169 |
| 60 | Agnosia (HP:0010524) | 2.48182830 |
| 61 | Osteomyelitis (HP:0002754) | 2.45347710 |
| 62 | Pathologic fracture (HP:0002756) | 2.41164120 |
| 63 | Progressive neurologic deterioration (HP:0002344) | 2.39707965 |
| 64 | Osteolytic defects of the hand bones (HP:0009699) | 2.39244692 |
| 65 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.39244692 |
| 66 | Petechiae (HP:0000967) | 2.37477936 |
| 67 | Vertebral compression fractures (HP:0002953) | 2.37120653 |
| 68 | Recurrent pneumonia (HP:0006532) | 2.35792062 |
| 69 | Upper motor neuron abnormality (HP:0002127) | 2.35410896 |
| 70 | Thick nail (HP:0001805) | 2.33255069 |
| 71 | Malnutrition (HP:0004395) | 2.31917787 |
| 72 | Pulmonary infiltrates (HP:0002113) | 2.31406065 |
| 73 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.28477908 |
| 74 | Recurrent cutaneous fungal infections (HP:0011370) | 2.27898479 |
| 75 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.27898479 |
| 76 | Asymmetric septal hypertrophy (HP:0001670) | 2.24481552 |
| 77 | Meningitis (HP:0001287) | 2.23451775 |
| 78 | Increased IgM level (HP:0003496) | 2.23366649 |
| 79 | Gingival bleeding (HP:0000225) | 2.23268657 |
| 80 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.23006741 |
| 81 | Inappropriate behavior (HP:0000719) | 2.22547711 |
| 82 | Hematochezia (HP:0002573) | 2.22263285 |
| 83 | Nausea (HP:0002018) | 2.21476938 |
| 84 | Metaphyseal irregularity (HP:0003025) | 2.19600564 |
| 85 | Poor head control (HP:0002421) | 2.17032548 |
| 86 | Personality changes (HP:0000751) | 2.15824452 |
| 87 | Arterial thrombosis (HP:0004420) | 2.15161916 |
| 88 | Amyloidosis (HP:0011034) | 2.12847565 |
| 89 | Dementia (HP:0000726) | 2.11580980 |
| 90 | Leukocytosis (HP:0001974) | 2.09932205 |
| 91 | Recurrent lower respiratory tract infections (HP:0002783) | 2.08705903 |
| 92 | Purpura (HP:0000979) | 2.07169089 |
| 93 | Bone pain (HP:0002653) | 2.06830467 |
| 94 | Hypergammaglobulinemia (HP:0010702) | 2.04130794 |
| 95 | Peritonitis (HP:0002586) | 2.03772523 |
| 96 | Prolonged neonatal jaundice (HP:0006579) | 2.02902847 |
| 97 | Spontaneous hematomas (HP:0007420) | 2.00417132 |
| 98 | Gastrointestinal infarctions (HP:0005244) | 1.98947300 |
| 99 | Peripheral demyelination (HP:0011096) | 1.98114894 |
| 100 | Xanthomatosis (HP:0000991) | 1.97022800 |
| 101 | Prostate neoplasm (HP:0100787) | 1.95449130 |
| 102 | Thrombocytosis (HP:0001894) | 1.94638926 |
| 103 | Abnormality of the lumbar spine (HP:0100712) | 1.93386789 |
| 104 | Colitis (HP:0002583) | 1.93325709 |
| 105 | Increased serum ferritin (HP:0003281) | 1.90687444 |
| 106 | Supranuclear gaze palsy (HP:0000605) | 1.88705986 |
| 107 | Cardiomegaly (HP:0001640) | 1.88518539 |
| 108 | Abnormality of the nasal mucosa (HP:0000433) | 1.87201997 |
| 109 | Restrictive lung disease (HP:0002091) | 1.86789801 |
| 110 | Abnormality of the periventricular white matter (HP:0002518) | 1.85548037 |
| 111 | Hemoptysis (HP:0002105) | 1.85089199 |
| 112 | Thoracic kyphosis (HP:0002942) | 1.82931725 |
| 113 | Epistaxis (HP:0000421) | 1.82612184 |
| 114 | Global brain atrophy (HP:0002283) | 1.80983750 |
| 115 | Conjunctival telangiectasia (HP:0000524) | 1.80190391 |
| 116 | Polyneuropathy (HP:0001271) | 1.80032734 |
| 117 | Gastrointestinal stroma tumor (HP:0100723) | 1.79802096 |
| 118 | J-shaped sella turcica (HP:0002680) | 1.78916322 |
| 119 | Abnormality of iron homeostasis (HP:0011031) | 1.78860615 |
| 120 | Esophageal varix (HP:0002040) | 1.78806435 |
| 121 | Hydroxyprolinuria (HP:0003080) | 1.76440349 |
| 122 | Abnormality of proline metabolism (HP:0010907) | 1.76440349 |
| 123 | Retinal atrophy (HP:0001105) | 1.76338809 |
| 124 | Premature loss of primary teeth (HP:0006323) | 1.76318919 |
| 125 | Increased CSF protein (HP:0002922) | 1.74673848 |
| 126 | Keratoconjunctivitis sicca (HP:0001097) | 1.74268154 |
| 127 | Thin bony cortex (HP:0002753) | 1.72863172 |
| 128 | Acrocyanosis (HP:0001063) | 1.72588002 |
| 129 | Spondylolisthesis (HP:0003302) | 1.72521750 |
| 130 | Protuberant abdomen (HP:0001538) | 1.68670462 |
| 131 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.65919200 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 3.87011475 |
| 2 | BLK | 3.65820549 |
| 3 | TBK1 | 3.65329241 |
| 4 | RIPK4 | 3.49747924 |
| 5 | TYK2 | 3.29956468 |
| 6 | ERN1 | 3.00753693 |
| 7 | IRAK4 | 2.97421745 |
| 8 | IRAK3 | 2.83412240 |
| 9 | PBK | 2.83393868 |
| 10 | MAP4K1 | 2.71307602 |
| 11 | PRPF4B | 2.55094537 |
| 12 | KIT | 2.55075794 |
| 13 | DDR2 | 2.32245043 |
| 14 | TAOK2 | 2.26703638 |
| 15 | IKBKB | 2.21941487 |
| 16 | IKBKE | 2.14640581 |
| 17 | JAK3 | 2.06931385 |
| 18 | PIM2 | 2.06269588 |
| 19 | TGFBR2 | 1.98173423 |
| 20 | NME2 | 1.92521803 |
| 21 | JAK1 | 1.86744073 |
| 22 | TAOK1 | 1.79580772 |
| 23 | NEK9 | 1.76984599 |
| 24 | CSF1R | 1.73423394 |
| 25 | ZAP70 | 1.62001279 |
| 26 | CDC42BPA | 1.57156372 |
| 27 | CSK | 1.48831110 |
| 28 | ABL2 | 1.43922584 |
| 29 | MST1R | 1.42035017 |
| 30 | TRIB3 | 1.41524522 |
| 31 | SYK | 1.39690873 |
| 32 | ACVR1B | 1.38887724 |
| 33 | BTK | 1.32490419 |
| 34 | TAOK3 | 1.31254243 |
| 35 | MAP3K13 | 1.26056758 |
| 36 | RPS6KA4 | 1.26011803 |
| 37 | CHUK | 1.25744327 |
| 38 | LYN | 1.20921054 |
| 39 | HCK | 1.19514613 |
| 40 | TXK | 1.16383979 |
| 41 | PKN2 | 1.14450206 |
| 42 | BMX | 1.13970105 |
| 43 | FGFR4 | 1.12023451 |
| 44 | JAK2 | 1.11934604 |
| 45 | STK10 | 1.11366973 |
| 46 | EPHB1 | 1.10445374 |
| 47 | MAP2K3 | 1.07064950 |
| 48 | TESK2 | 1.06978815 |
| 49 | TEC | 1.05887930 |
| 50 | PIM1 | 1.03713648 |
| 51 | MATK | 0.99038560 |
| 52 | LCK | 0.96920000 |
| 53 | LRRK2 | 0.93029214 |
| 54 | SCYL2 | 0.87331124 |
| 55 | ICK | 0.86421589 |
| 56 | MAP3K3 | 0.84843850 |
| 57 | PDGFRA | 0.82459685 |
| 58 | MAP3K11 | 0.81885314 |
| 59 | ARAF | 0.81665247 |
| 60 | FGR | 0.81485762 |
| 61 | SIK3 | 0.79672635 |
| 62 | PAK4 | 0.79252287 |
| 63 | MARK3 | 0.78175245 |
| 64 | IRAK2 | 0.77729671 |
| 65 | STK4 | 0.77066865 |
| 66 | PTK6 | 0.74633372 |
| 67 | FLT3 | 0.70887663 |
| 68 | PIK3CG | 0.70723826 |
| 69 | PRKCD | 0.70665919 |
| 70 | FES | 0.68788457 |
| 71 | EIF2AK2 | 0.68360211 |
| 72 | TRPM7 | 0.67854469 |
| 73 | TESK1 | 0.67594473 |
| 74 | ABL1 | 0.65614164 |
| 75 | GRK7 | 0.65197515 |
| 76 | MST4 | 0.65152070 |
| 77 | KDR | 0.65034186 |
| 78 | EGFR | 0.62906127 |
| 79 | MOS | 0.62753441 |
| 80 | PDK2 | 0.62590155 |
| 81 | ITK | 0.60447927 |
| 82 | RPS6KA2 | 0.59235346 |
| 83 | RIPK1 | 0.55737923 |
| 84 | KSR2 | 0.55328752 |
| 85 | ADRBK2 | 0.54927024 |
| 86 | TTN | 0.54582160 |
| 87 | CLK1 | 0.53254144 |
| 88 | MAP2K6 | 0.52143880 |
| 89 | EPHB2 | 0.50777928 |
| 90 | BMPR2 | 0.50716555 |
| 91 | MAPK7 | 0.50670060 |
| 92 | SIK1 | 0.49781218 |
| 93 | CAMK1D | 0.48037785 |
| 94 | SMG1 | 0.44526004 |
| 95 | EIF2AK1 | 0.43970933 |
| 96 | CDK6 | 0.43676473 |
| 97 | MAP3K10 | 0.43546286 |
| 98 | EPHA3 | 0.43432510 |
| 99 | MAPKAPK2 | 0.43399682 |
| 100 | FGFR3 | 0.42697830 |
| 101 | LIMK1 | 0.42045511 |
| 102 | TYRO3 | 0.41635265 |
| 103 | TNK2 | 0.40966701 |
| 104 | MAP3K5 | 0.40380224 |
| 105 | YES1 | 0.40033961 |
| 106 | EIF2AK3 | 0.39553340 |
| 107 | MARK2 | 0.38871327 |
| 108 | MAPK12 | 0.38730075 |
| 109 | MAP3K6 | 0.38706689 |
| 110 | PRKD2 | 0.38473754 |
| 111 | RPS6KA6 | 0.38385329 |
| 112 | STK3 | 0.37958313 |
| 113 | PDGFRB | 0.36957788 |
| 114 | TGFBR1 | 0.36262336 |
| 115 | MAP3K8 | 0.35060997 |
| 116 | LATS2 | 0.34401666 |
| 117 | GRK6 | 0.33726263 |
| 118 | SIK2 | 0.33422068 |
| 119 | PRKCQ | 0.33064997 |
| 120 | PRKG2 | 0.31591626 |
| 121 | IGF1R | 0.31276455 |
| 122 | FYN | 0.30947596 |
| 123 | DAPK3 | 0.29740459 |
| 124 | PDPK1 | 0.27970341 |
| 125 | MAPK4 | 0.27527600 |
| 126 | IRAK1 | 0.26727321 |
| 127 | RPS6KL1 | 0.26207365 |
| 128 | RPS6KC1 | 0.26207365 |
| 129 | CAMKK2 | 0.25449087 |
| 130 | MAP3K1 | 0.24900508 |
| 131 | PDK1 | 0.24157227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.83048256 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.16473394 |
| 3 | * Lysosome_Homo sapiens_hsa04142 | 2.78111816 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.60182452 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.55986494 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.53085016 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.47874483 |
| 8 | Pertussis_Homo sapiens_hsa05133 | 2.26071339 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.25414147 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.22564488 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.20522784 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 2.15140243 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.14690579 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.13437679 |
| 15 | Phagosome_Homo sapiens_hsa04145 | 1.92726533 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.90014614 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.89919677 |
| 18 | Allograft rejection_Homo sapiens_hsa05330 | 1.87475242 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.81109686 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.80766981 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.74616377 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.66968188 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.64201016 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.61624318 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.47383065 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.47305995 |
| 27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.43325488 |
| 28 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.42878731 |
| 29 | Asthma_Homo sapiens_hsa05310 | 1.42307597 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.40224066 |
| 31 | Salmonella infection_Homo sapiens_hsa05132 | 1.38903520 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.36357663 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27202801 |
| 34 | * Apoptosis_Homo sapiens_hsa04210 | 1.26448368 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.22699198 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.17224365 |
| 37 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.14885857 |
| 38 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.12833102 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.12343319 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.10287510 |
| 41 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.09444121 |
| 42 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.07806999 |
| 43 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.02663505 |
| 44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.00970920 |
| 45 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.99942619 |
| 46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.99935275 |
| 47 | Bladder cancer_Homo sapiens_hsa05219 | 0.98490791 |
| 48 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.97505906 |
| 49 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.93703035 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93115828 |
| 51 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.92269222 |
| 52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.90083813 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.89951845 |
| 54 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.85433486 |
| 55 | Prion diseases_Homo sapiens_hsa05020 | 0.85374120 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81615129 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 0.80492984 |
| 58 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.77813690 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.76965262 |
| 60 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.75668012 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74935930 |
| 62 | Amoebiasis_Homo sapiens_hsa05146 | 0.73976990 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71706673 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69487501 |
| 65 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.68291218 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.68139089 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66384614 |
| 68 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.65627823 |
| 69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.65595811 |
| 70 | Histidine metabolism_Homo sapiens_hsa00340 | 0.63028734 |
| 71 | Proteasome_Homo sapiens_hsa03050 | 0.62302130 |
| 72 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60585207 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59636563 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59619775 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59578096 |
| 76 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59466536 |
| 77 | Peroxisome_Homo sapiens_hsa04146 | 0.58829775 |
| 78 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.57773378 |
| 79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.57759045 |
| 80 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.57722642 |
| 81 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.56468140 |
| 82 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.56044977 |
| 83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54048565 |
| 84 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.51874558 |
| 85 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51729613 |
| 86 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51492706 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50487457 |
| 88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50013473 |
| 89 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46679267 |
| 90 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.46641973 |
| 91 | Endocytosis_Homo sapiens_hsa04144 | 0.46270269 |
| 92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.41034559 |
| 93 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.40096744 |
| 94 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.40038991 |
| 95 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.39574828 |
| 96 | ABC transporters_Homo sapiens_hsa02010 | 0.39368507 |
| 97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37827042 |
| 98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36721672 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.36675431 |
| 100 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.36593665 |
| 101 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.34897727 |
| 102 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.34733497 |
| 103 | Platelet activation_Homo sapiens_hsa04611 | 0.34465250 |
| 104 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.33502921 |
| 105 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.32014883 |
| 106 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31491174 |
| 107 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.30770477 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28978813 |
| 109 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.28969114 |
| 110 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.28064117 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.27491404 |
| 112 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.26947912 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.26426747 |
| 114 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.26351055 |
| 115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.25012086 |
| 116 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.24464968 |
| 117 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24184176 |
| 118 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.23972637 |
| 119 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.22820363 |
| 120 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.22103615 |
| 121 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.19576328 |
| 122 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.14903356 |

